TY  - GEN
AU  - Shang,Zhiqun
AU  - Li,Yanjun
AU  - Zhang,Minghao
AU  - Tian,Jing
AU  - Han,Ruifa
AU  - Shyr,Chih-Rong
AU  - Messing,Edward
AU  - Yeh,Shuyuan
AU  - Niu,Yuanjie
AU  - Chang,Chawnshang
TI  - Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression
SN  - 1538-8514
PY  - 2016///0906
KW  - Androgen Antagonists
KW  - administration & dosage
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - BCG Vaccine
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - drug effects
KW  - Cell Survival
KW  - Curcumin
KW  - Disease Progression
KW  - Drug Synergism
KW  - Female
KW  - Flutamide
KW  - Gene Expression
KW  - Humans
KW  - Integrin alpha5beta1
KW  - genetics
KW  - Interleukin-6
KW  - Macrophages
KW  - Mice
KW  - Receptors, Androgen
KW  - metabolism
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Treatment Outcome
KW  - Urinary Bladder Neoplasms
KW  - drug therapy
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1535-7163.MCT-14-1055-T
ER  -